Resources
25 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 11/30/2021 (updated 3/26/2024)
Peer providers are viable, evidence based, stand alone or additions to comprehensive teams that approach struggle interventions. Peer providers can be appropriate for any environment that have people with challenges ranging from substance use, gun violence, domestic violence to mental health experiences.
Learning Objectives:
What are the certifications that a peer provider can receive? You will walk away knowing various ways peers can show up in the workplace.
What additional training do peer providers need? Information on what trainings would be helpful for peers to be able to support others well will be provided.
How do we find, support and retain peer providers in the work place? Knowing where to recruit peers, how to keep the workplace well for peer will be knowledge you will leave with.
Presenter: Tanya Kraege
Posted 8/25/2023 (updated 3/26/2024)
The National Institute for Health Care Management (NIHCM) provided interactive graphic reports on the trends in overdose deaths using the latest data. The interactive infographic shows the effects combined drugs, such as fentanyl and xylazine, have on overdoses.
Posted 9/4/2023 (updated 3/26/2024)
Two reports are now available from Fors Marsh, a research and communications firm who's reports work to highlight system problems like SUD. The "Road Map for Advancing a Recovery-Ready Nation" report examines recovery research and covers issues such as support services, housing, employment, workforce, stigma, etc. The "2022 Workplace Recovery Survey Report" covers background and understanding recovery in the workplace, policies, culture, experiences, and much more.
Posted 2/16/2022 (updated 3/26/2024)
In the United States, combined stimulant/opioid overdose mortality has risen dramatically over the last decade. These increases may particularly affect non-Hispanic Black and Hispanic populations. We used death certificate data from the US National Center for Health Statistics (2007–2019) to compare state-level trends in overdose mortality due to opioids in combination with 1) cocaine and 2) methamphetamine and other stimulants (MOS) across racial/ethnic groups (non-Hispanic White, non-Hispanic Black, Hispanic, and non-Hispanic Asian American/Pacific Islander).
Posted 5/4/2022 (updated 3/27/2024)
Data supporting the positive outcomes associated with peer support integration throughout the substance use disorder continuum of intervention and care has led nationally to systems integrating members of this relatively new workforce into their teams. Among most peer certifying authorities, sustained recovery from substance use disorder is one of the requirements to become a peer. Although substance use recurrence or “relapse” is not common among those in sustained recovery, it does happen. This webinar will introduce suggested considerations when attempting to draft model recurrence policy for peer support employers.
Posted 5/10/2022 (updated 3/27/2024)
Fentanyl is a synthetic opioid typically used to treat patients with chronic severe pain or severe pain following surgery. Fentanyl is a Schedule II controlled substance that is similar to morphine but about 100 times more potent. Under the supervision of a licensed medical professional, fentanyl has a legitimate medical use. Patients prescribed fentanyl should be monitored for potential misuse or abuse.
Posted 5/11/2022 (updated 3/27/2024)
The rate of drug overdose deaths in the USA has more than tripled since the turn of the century, and rates are disproportionately high among the American Indian/Alaska Native (AI/AN) population. Little is known about the overall historical trends in AI/AN opioid-only and opioid/polysubstance-related mortality. This study will address this gap.
Posted 7/25/2022 (updated 3/27/2024)
The interactive graphics allow readers to explore how the crisis of overdose deaths involving opioid use has not only grown in magnitude since 2000, but has also changed in character.
Posted 8/17/2022 (updated 3/27/2024)
This presentation will detail the efforts behind the grant to develop a Recovery Friendly Workplace credential through training, technical assistance, and support that assists businesses in fostering a workplace culture that promotes employee safety, health, and well-being.
Posted 8/23/2022 (updated 3/27/2024)
This observational study of 719 612 pharmacy claims data shows that OOP costs of naloxone grew substantially beginning in 2016. However, OOP costs did not increase for all patients and all brands of naloxone but primarily for uninsured patients and for the Evzio brand. The findings suggest that the OOP cost of naloxone has been an increasingly substantial barrier to naloxone access for uninsured patients, a population that constitutes nearly one-fifth of adults with opioid use disorder.